Postdoc opening on subgroup analysis and risk-benefit analysis at Merck pharmaceuticals research lab http://andrewgelman.com/2018/01/29/postdoc-opening-subgroup-analysis-risk-benefit-analysis-merck-pharmaceuticals-research-lab/ …
5:41 PM - 29 Jan 2018
0 replies
3 retweets
10 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.